1 results match your criteria: "Veterans Affairs Medical Center and University of Iowa School of Medicine[Affiliation]"
Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial.
Clin Trials
January 2006
Nephrology Division, Veterans Affairs Medical Center and University of Iowa School of Medicine, Iowa City 52242-1081, USA.
Background: Surgically created arteriovenous (AV) grafts are the most common type of hemodialysis vascular access in the United States, but fail frequently due to the development of venous stenosis. The Dialysis Access Consortium (DAC) Aggrenox Prevention of Access Stenosis Trial tests the hypothesis that Aggrenox (containing dipyridamole and aspirin) can prevent stenosis and prolong survival of arteriovenous grafts.
Methods: This is a multicenter, randomized, double-blind, placebo-controlled trial that will enroll 1056 subjects over four years with one-half year follow-up.